Just over a month ago, President Trump promised to lower drug prices.
MAY 30 2018 –
Bloomberg: Trump Says Drug Companies to Unveil Price Cuts in Two Weeks
“Major pharmaceutical companies will announce ‘voluntary, massive’ cuts in drug prices in two weeks, President Donald Trump said Wednesday, without providing details. ‘We’re also working very hard at getting the cost of medicine down, and I think people are going to start to see for the first time ever in this country a major drop in the cost of prescription drugs,’ Trump said while signing legislation making it easier for terminally ill patients to get access to experimental drugs.”
How’s that going?
JULY 2, 2018 –
Financial Times reports several U.S. drugmakers have raised their prices significantly:
- The smoking cessation drug Chantix ”has gone up 17 percent this year.”
- The multiple sclerosis drug Ampyra has been raised 9.5 percent, “taking a bottle of 60 to more than $3,000.”
- The liver medication Ocaliva has been raised “7 percent to $263.48 per pill or nearly $8,000 for a pack of 30”
Read the Financial Times story here.